ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,412.69
0.83%
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs Yen
153.055
0.01%
Brent Oil
82.765
0.00%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Vivos Therapeutics Inc (VVOS)

  7. Vivos Therapeutics Inc (VVOS) ニュース

VVOS Vivos Therapeutics Inc

2.63
0.00 (0.00%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Vivos Therapeutics Inc VVOS NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
0.00 0.00% 2.63 13:00:09
始値 安値 高値 終値 前日終値
2.70 2.56 2.715 2.63 2.63
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/0920:30GLOBEVivos Therapeutics’ Flagship CARE Oral Medical Devices..
2024/3/2905:05GLOBEVivos Therapeutics Reports Fourth Quarter and Full Year 2023..
2024/3/2820:30GLOBEVivos Therapeutics Schedules Release of Fourth Quarter and..
2024/2/1522:55EDGAR2Form 8-K - Current report
2024/2/1522:00GLOBEVivos Therapeutics Announces Exercise of Warrants for..
2024/2/1507:42EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0621:30GLOBEVivos Therapeutics Highlights Significant Favorable Market..
2024/1/0821:30GLOBEVivos Therapeutics Sees Positive Preliminary Metrics..
2023/12/1121:30GLOBEVivos Therapeutics Presents Groundbreaking Event:..
2023/12/0414:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/12/0206:12EDGAR2Form 424B1 - Prospectus [Rule 424(b)(1)]
2023/12/0106:05EDGAR2Form 8-K - Current report
2023/12/0106:03EDGAR2Form S-1/A - General form for registration of securities..
2023/11/2921:30GLOBEVivos Therapeutics Receives First Ever FDA 510(k) Clearance..
2023/11/2306:46EDGAR2Form S-1 - General form for registration of securities under..
2023/11/1506:05GLOBEVivos Therapeutics Reports Third Quarter 2023 Financial..
2023/11/1006:30GLOBEVivos Therapeutics Schedules Release of Third Quarter 2023..
2023/11/0406:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/11/0306:10EDGAR2Form 8-K - Current report
2023/11/0306:00GLOBEVivos Therapeutics Closes $4 Million Private Placement
2023/10/3121:00GLOBEVivos Therapeutics Announces Pricing of $4 Million Private..
2023/10/2805:15EDGAR2Form 8-K - Current report
2023/10/2620:30GLOBEVivos Therapeutics Announces Reverse Stock Split
2023/10/2420:30GLOBEVivos Therapeutics Signs Nationwide Distribution Agreement..
2023/10/1120:30GLOBEVivos Therapeutics to Begin Clinical Trial at Stanford..
2023/10/0520:30GLOBEVivos Therapeutics Announces Strategic Collaboration in the..
2023/10/0504:55APSBiotech Soars On New Agreements
2023/10/0420:30GLOBEVivos Therapeutics Executes Strategic Agreements with Ormco..
2023/10/0220:30GLOBENew York Times Best-Selling Author James Nestor to Headline..
2023/9/2522:00EDGAR2Form 8-K - Current report
2023/9/2206:10EDGAR2Form 8-K - Current report
2023/9/1505:38EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/9/0706:26EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/8/2822:00EDGAR2Form DEF 14A - Other definitive proxy statements
2023/8/2122:00EDGAR2Form 8-K - Current report
2023/8/1705:45EDGAR2Form PRE 14A - Other preliminary proxy statements
2023/8/1705:30EDGAR2Form 8-K - Current report
2023/8/1705:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1705:05GLOBEVivos Therapeutics Reports Second Quarter 2023 Financial..
2023/8/1620:30GLOBEVivos Therapeutics Reschedules Second Quarter 2023 Financial..
2023/8/1506:06GLOBEVivos Therapeutics to Reschedule Second Quarter 2023..
2023/8/1109:31GLOBEVivos Therapeutics Schedules Release of Second Quarter 2023..
2023/6/0905:05GLOBEVivos Therapeutics Reports First Quarter 2023 Financial..
2023/6/0705:30GLOBEVivos Therapeutics Schedules Release of First Quarter..
2023/5/0920:30GLOBEVivos Therapeutics Announces Additional Strategic..

最近閲覧した銘柄

NASDAQ
VVOS
Vivos Therapeutics
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有